Compare stocks

Demant A/S is a Danish company that operates in the healthcare industry, primarily focusing on hearing health. The company designs, develops, and manufactures hearing aids, audiometric equipment, and personal communication devices. Established in 1904, Demant has grown to become a globally recognized player in the hearing healthcare sector. Headquartered in Smørum, Denmark, Demant's products and services are available worldwide through a network of subsidiaries and distributors. The company is noted for integrating advanced technology into its offerings, allowing for improved user experiences and health outcomes. Its strategic position is strengthened by a continuous focus on innovation and a comprehensive product portfolio that caters to various aspects of hearing health.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.